CLINICAL_TRIALS
research
· 2026-03-06
Clinical Trial Update: COMPASSION S3 - Evaluation of the SAPIEN 3 Transcatheter Heart Valve in Patients With Pulmonary Valve Dysfunction [NA]
Summary
This clinical trial update reports that the COMPASSION S3 study evaluating the SAPIEN 3 transcatheter heart valve for pulmonary valve dysfunction is currently r…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Edwards Lifesciences | Conditions: Complex Congenital Heart Defect, Dysfunctional RVOT Conduit | NA | Status: RECRUITING